series-a
Stage
1
Investors
About
Sidera Bio develops transformative cardiometabolic therapies by harnessing human genetics to deliver innovative medicines for patients.
Explore Sidera Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.